The essence of this SCOR proposal encompasses the development of a unified research effort to understand the processes that influence CI- secretion in airway epithelia, and the role of CI- secretory pathways in CF pathogenesis. The thrust of each component is to focus on a well-defined and integrated set of problems that range from the elucidation and correction of translational defects in CFTR, to novel features of CFTR regulation in vitro and in vivo, means by which alternative Cl-secretory pathways may genetically modify the CF phenotype, ways in which other membrane proteins (e.g., p11, annexins) govern CFTR regulation, and features of human pulmonary physiology that influence disease progression. The present projects in this SCOR include four research program leaders and two core directors with long-standing dedication to CF research. The four projects and two cores described in this SCOR proposal are not only synergistic but in fact require each other in order to succeed. These include: """"""""CFTR Regulation by the p11-annexin II Complex,"""""""" K.L. Kirk, Ph.D., """"""""Alternate Cl- Secretory Pathways in Cystic Fibrosis, D.J. Benos, Ph.D., """"""""Pharmacological Suppression of CFTR Stop Mutations, D.M. Bedwell, Ph.D., """"""""Mouse Genetics Core,"""""""" R. Rozmahel, Ph.D., """"""""Assay Core,"""""""" E.M. Schwiebert. Because all projects within the SCOR share the same goal, they are interactive and mutually reinforcing. In summary, we propose an aggressive, multi-pronged attack aimed at developing a comprehensive and mechanistic understanding of CI- secretion in CF pathophysiology.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Specialized Center (P50)
Project #
2P50DK053090-06
Application #
6545371
Study Section
Special Emphasis Panel (ZDK1-GRB-8 (M1))
Program Officer
Mckeon, Catherine T
Project Start
1997-09-30
Project End
2007-08-31
Budget Start
2002-09-01
Budget End
2003-08-31
Support Year
6
Fiscal Year
2002
Total Cost
$879,326
Indirect Cost
Name
University of Alabama Birmingham
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Du, Ming; Keeling, Kim M; Fan, Liming et al. (2009) Poly-L-aspartic acid enhances and prolongs gentamicin-mediated suppression of the CFTR-G542X mutation in a cystic fibrosis mouse model. J Biol Chem 284:6885-92
Du, Ming; Liu, Xiaoli; Welch, Ellen M et al. (2008) PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model. Proc Natl Acad Sci U S A 105:2064-9
Guimbellot, Jennifer S; Fortenberry, James A; Siegal, Gene P et al. (2008) Role of oxygen availability in CFTR expression and function. Am J Respir Cell Mol Biol 39:514-21
Berdiev, Bakhrom K; Cormet-Boyaka, Estelle; Tousson, Albert et al. (2007) Molecular proximity of cystic fibrosis transmembrane conductance regulator and epithelial sodium channel assessed by fluorescence resonance energy transfer. J Biol Chem 282:36481-8
Rowe, Steven M; Varga, Karoly; Rab, Andras et al. (2007) Restoration of W1282X CFTR activity by enhanced expression. Am J Respir Cell Mol Biol 37:347-56
Gaggar, Amit; Li, Yao; Weathington, Nathaniel et al. (2007) Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients. Am J Physiol Lung Cell Mol Physiol 293:L96-L104
Benos, Dale J; Bashari, Edlira; Chaves, Jose M et al. (2007) The ups and downs of peer review. Adv Physiol Educ 31:145-52
Kellermayer, Richard; Szigeti, Reka; Keeling, Kim M et al. (2006) Aminoglycosides as potential pharmacogenetic agents in the treatment of Hailey-Hailey disease. J Invest Dermatol 126:229-31
Su, Xuefeng; Li, Qingnan; Shrestha, Kedar et al. (2006) Interregulation of proton-gated Na(+) channel 3 and cystic fibrosis transmembrane conductance regulator. J Biol Chem 281:36960-8
Du, Ming; Keeling, Kim M; Fan, Liming et al. (2006) Clinical doses of amikacin provide more effective suppression of the human CFTR-G542X stop mutation than gentamicin in a transgenic CF mouse model. J Mol Med 84:573-82

Showing the most recent 10 out of 37 publications